UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

Arteriosclerosis, thrombosis, and vascular biology, 2002-09, Vol.22 (9), p.1500-1505

2002

Volltextzugriff (PDF)

Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2192-2198

2003

Volltextzugriff (PDF)

Immune checkpoint inhibitor–associated myocarditis: Case reports and a review of the literature

Netherlands heart journal, 2022-06, Vol.30 (6), p.295-301

2022

Volltextzugriff (PDF)

Effect of Providing Cancer Patients With the Audiotaped Initial Consultation on Satisfaction, Recall, and Quality of Life: A Randomized, Double-Blind Study

Journal of clinical oncology, 2000-08, Vol.18 (16), p.3052-3060

2000

Volltextzugriff (PDF)

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

British journal of cancer, 2012-05, Vol.106 (11), p.1728-1734

2012

Volltextzugriff (PDF)

Immune checkpoint inhibitor–associated myocarditis

Netherlands heart journal, 2022-06, Vol.30 (6), p.295-301

2022

Volltextzugriff (PDF)

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1657-1667

Kuenen, B. C.

2002

Volltextzugriff (PDF)

Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

Annals of oncology, 2009-09, Vol.20 (9), p.1565-1575

2009

Volltextzugriff (PDF)

The role of thrombopoietin in post‐operative thrombocytosis

British journal of haematology, 2001-07, Vol.114 (1), p.126-133

2001

Volltextzugriff (PDF)

Feasibility Study of Erlotinib (tarcevaR ) Plus Radiotherapy in Patients with Locally Advanced or Recurrent Rectal Carcinoma

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S69-S70

2008

Volltextzugriff (PDF)

A patient with a VEGF and endostatin producing gastrointestinal autonomic nerve tumour

Journal of clinical pathology, 2004-05, Vol.57 (5), p.536-538

2004

Volltextzugriff (PDF)

Intravenous leiomyomatosis complicated by Budd—Chiari syndrome

Postgraduate medical journal, 1996-11, Vol.72 (853), p.686-688

1996

Volltextzugriff (PDF)

Mondor's disease as first thrombotic event in hereditary protein C deficiency and anticardiolipin antibodies

Netherlands journal of medicine, 1997-02, Vol.50 (2), p.85-87

1997

Volltextzugriff (PDF)

Non-islet-cell tumour induced hypoglycaemia: a case report and review of literature

Netherlands journal of medicine, 1996-05, Vol.48 (5), p.175-179

1996

Volltextzugriff (PDF)

Efficacy and Toxicity of the Angiogenesis Inhibitor SU5416 As a Single Agent in Patients with Advanced Renal Cell Carcinoma, Melanoma, and Soft Tissue Sarcoma

Clinical cancer research, 2003-05, Vol.9 (5), p.1648

2003

Volltextzugriff (PDF)

Dose-Finding Study of the Multitargeted Tyrosine Kinase Inhibitor SU6668 in Patients with Advanced Malignancies

Clinical cancer research, 2005-09, Vol.11 (17), p.6240-6246

2005

Volltextzugriff (PDF)

Phase lb safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

Annals of oncology, 2009, Vol.20 (9), p.1565-1575

2009

Volltextzugriff (PDF)

Case report. Infarcering van een testis bij een patiënt met sikkelcelanemie

Tijdschrift voor urologie, 2017-12, Vol.7 (8), p.188-190

2017

Volltextzugriff (PDF)

Comparison of enzastaurin pharmacokinetics and safety in the once daily (QD) and twice daily (BID) dose regimens: A phase I study

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.14021-14021

2007

Volltextzugriff (PDF)

Myocardial ischaemia as a result of treatment with capecitabine

Nederlands tijdschrift voor geneeskunde, 2007-09, Vol.151 (36), p.2016; author reply 2016

2007

Volltextzugriff (PDF)

A phase I study of IMC-11F8, a fully human anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in patients with solid tumors. Interim results

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3024-3024

2006

Volltextzugriff (PDF)

Pharmacokinetic interaction and safety of enzastaurin and pemetrexed in patients with advanced or metastatic cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2047-2047

2006

Volltextzugriff (PDF)

Phase I Trial with BMS-275183, a Novel Oral Taxane with Promising Antitumor Activity

Clinical cancer research, 2006-03, Vol.12 (6), p.1760-1767

2006

Volltextzugriff (PDF)

Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor

Clinical & developmental immunology, 2007, Vol.2007, p.17315-17315

2007

Volltextzugriff (PDF)

A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.2103-2103

2005

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(65)
Biological And Medical Sciences
(43)
Humans
(35)
Female
(28)
Middle Aged
(24)
Medical Sciences
(22)
Fundamental And Applied Biological Sciences. Psychology
(21)
Adult
(19)
Male
(18)
Oncology
(18)
Microbiology
(16)
Aged
(15)
Physical Sciences
(12)
Biotechnology
(11)
Environmental Sciences
(10)
Oxidation-Reduction
(9)
Air Pollution
(8)
Bacteria
(8)
Emissions
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416

Immune checkpoint inhibitor–associated myocarditis: Case reports and a review of the literature

Effect of Providing Cancer Patients With the Audiotaped Initial Consultation on Satisfaction, Recall, and Quality of Life: A Randomized, Double-Blind Study

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Immune checkpoint inhibitor–associated myocarditis

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

The role of thrombopoietin in post‐operative thrombocytosis

Feasibility Study of Erlotinib (tarcevaR ) Plus Radiotherapy in Patients with Locally Advanced or Recurrent Rectal Carcinoma

A patient with a VEGF and endostatin producing gastrointestinal autonomic nerve tumour

Intravenous leiomyomatosis complicated by Budd—Chiari syndrome

Mondor's disease as first thrombotic event in hereditary protein C deficiency and anticardiolipin antibodies

Non-islet-cell tumour induced hypoglycaemia: a case report and review of literature

Efficacy and Toxicity of the Angiogenesis Inhibitor SU5416 As a Single Agent in Patients with Advanced Renal Cell Carcinoma, Melanoma, and Soft Tissue Sarcoma

Dose-Finding Study of the Multitargeted Tyrosine Kinase Inhibitor SU6668 in Patients with Advanced Malignancies

Phase lb safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

Case report. Infarcering van een testis bij een patiënt met sikkelcelanemie

Comparison of enzastaurin pharmacokinetics and safety in the once daily (QD) and twice daily (BID) dose regimens: A phase I study

Myocardial ischaemia as a result of treatment with capecitabine

A phase I study of IMC-11F8, a fully human anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in patients with solid tumors. Interim results

Pharmacokinetic interaction and safety of enzastaurin and pemetrexed in patients with advanced or metastatic cancer

Phase I Trial with BMS-275183, a Novel Oral Taxane with Promising Antitumor Activity

Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor

A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study

Suchergebnisse filtern